Skip to main content

Advertisement

SpringerLink
Log in

A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation

  • Case Report
  • Published:
Infection Aims and scope Submit manuscript

Summary

The case described concerns a 68-year-old male patient, who received intravesical BCG instillations for non-resectable urothelial carcinoma (stage pT1, G2). After the third instillation, which was complicated by hematuria during catheterization, he had a high temperature, dyspnoea, a weight-loss of 15 kg and critical recurrent hypotension for 3 weeks. On admission to the clinic he presented with high serum liver enzymes and pancytopenia. The suspected diagnosis of BCG sepsis was confirmed by the detection of typical granulomas in liver and bone marrow histology. After initiation of tuberculostatic therapy, the patient's condition improved and laboratory results returned to normal. This case shows the potential of a life-threatening systemic side effect after intravesical BCG instillation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Witjes, J. A., van der Meijden, A. P. M., Witjes, W. P. W., Doesburg, W., Schaafsma, H., Debruyne, F. J. M. and the members of the Dutch Sout-East Cooperative Urological Group: A randomised prospective study comparing intravesical instillations of mitomycin-C, BCG-Tice and BCG-RIVM in pTa-pT1 tumours and primary carcinomain situ of the urinary bladder. Eur. J. Cancer 12 (1993) 1672–1676.

    Article  Google Scholar 

  2. Debruyne, F. M. J., van der Meijden, A. P. M., Witjes, J. A., Fransen, M. P. H., Steerenberg, P. A., De Jong, W. W., Read, J., van Leeuwen, M. J. W., Hammond, B., Sylvester, R.: Bacillus Calmette-Guérin versus mitomycin-C intravesical therapy in superficial bladder cancer. Results of a randomized trial after 21 months of follow-up. Suppl. Urology 40 (1992) 11–15.

    Article  Google Scholar 

  3. Steg, A., Adjiman, S., Debré, B.: BCG therapy in superficial bladder tumours—complications and precautions. Eur. Urol. 2 (Suppl. 2) (1992) 35–40.

    Google Scholar 

  4. Lamm, D. L.: Complications of bacillus Calmette-Guérin immunotherapy. Urol. Clin. North Am. 19 (1992) 565–572.

    PubMed  CAS  Google Scholar 

  5. Lamm, D., van der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A., Debruyne, F. M. J.: Incidence and treatment of complications of BCG intravesical therapy in superficial bladder cancer. J. Urol. 147 (1992) 596–600.

    PubMed  CAS  Google Scholar 

  6. Brosman, S. A., Lamm, D. L., v. d. Meijden, A. P. M., debruyne, F. M. J.: A practical guide to the use of intravesical BCG for the management of Stage Ta, T1, CIS, transitional cell cancer. In:Debruyne, F. M. J., Denis, L.;v. d. Meijden, A. P. M. (eds.): EORTC genito-urinary group monograph 6: BCG in superficial bladder cancer. Alan R. Riss Inc., New York 1989, pp. 311–323.

    Google Scholar 

  7. Flippin, T., Mukherij, B., Dayal, Y.: Granulomatous hepatitis as a late complication of BCG immunotherapy. Cancer 46 (1980) 1759.

    Article  PubMed  CAS  Google Scholar 

  8. Rosenberg, S. A., Seipp, C., Sears, H. F.: Clinical and immunologic studies of disseminated BCG infection. Cancer 41 (1978) 1771.

    Article  PubMed  CAS  Google Scholar 

  9. Blondon, H., Guez, T., Paul, G., Truffot Pernot, C., Sicard, D.: Adénite à BCG 6 ans après la vaccination au cours d'un sida. Presse Méd. 20 (1991) 1091.

    PubMed  CAS  Google Scholar 

  10. Reynes, J., Perez, C., Lamaury, I., Janzow, F., Bertrand, A.: Bacillus Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS. J. Infect. Dis. 160 (1989) 727.

    PubMed  CAS  Google Scholar 

  11. Pinsky, C. M., Hirshault, Y., Oettgen, H.: Treatment of malignant melanoma by intra-tumoral injection of BCG. Natl. Cancer Inst. Monograph 39 (1973) 225–228.

    CAS  Google Scholar 

  12. Molina, J.-M., Rabian, C., d'Ágay, M.-F., Modai, J.: Hypersensitivity systemic reaction following intravesical BCG: successful treatment with steroids. J. Urol. 147 (1992) 695–697.

    PubMed  CAS  Google Scholar 

  13. Israel-Biet, D., Venet, A., Sandron, D., Ziza, J. M., Chretien, J.: Pulmonary complications of intravesical bacille Calmette-Guérin immunotherapy. Amer. Rev. Resp. Dis. 135 (1987) 761.

    Google Scholar 

  14. DeHertogh, D., Fierer, E., Orell, J. A.: Hypersensitivity reaction to bacillus Calmette-Guérin treated with plasmapheresis. Amer. J. Med. 86 (1989) 343.

    Article  PubMed  CAS  Google Scholar 

  15. Le Mense, G., Strange, C.: Granulomatous pneumonitis following intravesical GCG—what therapy is needed? Chest 5 (1994) 1624–1625.

    Article  Google Scholar 

  16. Gupta, R. C., Lavengood, R., Smith, J. P.: Miliary tuberculosis due to intravesical bacillus Calmette-Guérin therapy. Chest 94 (1988) 1296–1298.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abt. für Innere Medizin-Gastroenterologie, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, D-12200, Berlin, Germany

    B. Dederke & E. -O. Riecken

  2. Abt. für Gastroenterologie und Infektiologie, Klinikum Ernst von Bergmann, Charlottenstr. 72, D-14467, Potsdam, Germany

    T. Weinke

Authors
  1. B. Dederke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. -O. Riecken
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Weinke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dederke, B., Riecken, E.O. & Weinke, T. A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation. Infection 26, 54–57 (1998). https://doi.org/10.1007/BF02768758

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02768758

Keywords

Search

Navigation